Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Indonesia ETF (EIDO) vs Herbalife Nutrition Ltd (HLF) Price & Performance

iShares MSCI Indonesia ETFTrade
Herbalife Nutrition LtdTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Indonesia ETF vs Herbalife Nutrition Ltd — how do they compare? iShares MSCI Indonesia ETF trades at $11.91 (market cap $409.22M), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: Herbalife Nutrition Ltd is far larger — about 3.3× iShares MSCI Indonesia ETF's market cap, and Herbalife Nutrition Ltd is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Indonesia ETF for 76 Days and Herbalife Nutrition Ltd for 43 Days on average.

EIDOHLF
Market Cap
$409.22M$1.34B
Volume
879,5271,589,457
52-Week High
$19.22$19.96
52-Week Low
$10.80$7.75
Typical Hold Time
76 Days43 Days
Sector
—Consumer Staples
Enterprise Value
—$3.18B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Indonesia ETF

EIDO trades at $11.87, showing minimal daily movement with a 0.08% gain. Technical indicators signal a bearish trend, with moving averages and ADX pointing downward, though RSI levels hint at potential oversold conditions. Recent news highlights underperformance amid sector rotation away from Asian equities, with volume declining 21% below average. Key financial ratios are unavailable in the provided data, limiting fundamental assessment.

The outlook remains cautious due to weak price action and bearish technicals. Risks include high financials exposure and slow EPS growth. Upside may depend on seasonal trends or valuation support, but current sentiment and institutional flows suggest continued pressure. Investors should weigh technical weakness against potential bargain opportunities.

Herbalife Nutrition Ltd

Herbalife (HLF) trades at $12.86, up 1.62% on the day, with a bullish technical signal and a consensus analyst price target of $19.00 implying significant upside. The company reported Q2 2026 EPS of $0.51, missing expectations, but reaffirmed full-year 2026 guidance. Financials show a net income margin of 3.16% for 2025, with a low P/E of 8.22 and P/S of 0.26, suggesting potential undervaluation. Recent news includes a $250 million share repurchase authorization and a planned CEO transition effective October 31, 2026.

The outlook for HLF is cautiously optimistic, with valuation metrics and analyst sentiment supporting a bullish case, but risks include recent earnings misses, high debt levels, and ongoing leadership changes. The stock presents a value opportunity if the company can execute on its growth and margin expansion plans while managing its leverage.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EIDO
92% Buy8% Sell
Avg holding period · 76 Days
HLF
100% Buy0% Sell
Avg holding period · 43 Days

About iShares MSCI Indonesia ETF

The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.

Read more on EIDO →

About Herbalife Nutrition Ltd

Herbalife Nutrition Ltd is an international nutrition company.

Read more on HLF →